1 / 5

Biosimilars Market Size, Trends, Share, Growth and Forecast 2029

Biosimilars Market: By-Drug Class (Monoclonal Antibodies, Recombinant Hormones, Recombinant Growth Factors, Immunomodulators, Anti-Inflammatory Agents, and Others), By Application (Oncology, Blood Disorders, Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Diabetes, and Others), By Manufacturing Type (Captive and Out-sourcing), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

MathurReshma
Download Presentation

Biosimilars Market Size, Trends, Share, Growth and Forecast 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biosimilars Market (2023-2029)

  2. Market Overview: Biosimilars Market size was valued at USD 14.8 billion in 2022 and is expected to be USD 45.3 billion by 2029 and is poised to grow at a CAGR of 23.9% from 2023 to 2029. The Biosimilars Market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of theBiosimilars Market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description

  3. Market Segments: The Biosimilars Market has been fragmented based on: 1) By Drug Class: Monoclonal Antibodies, Recombinant Hormones, Recombinant Growth Factors, Immunomodulators, Anti-Inflammatory Agents, and Others 2) By Application: Oncology, Blood Disorders, Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Diabetes, and Others 3) By Manufacturing Type: Captive and Out-sourcing 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Request Sample Report

  4. Key Players: • Some of the major key players in the Biosimilars Market are: • Amgen Inc. (U.S.) • Biocon Ltd. (India) • Celltrion, Inc. (South Korea) • Dr. Reddys Laboratories Ltd. (India) • F. Hoffmann-La Roche Ltd. (Switzerland) • Pfizer Inc. (U.S.) • Samsung Bioepis (South Korea) • Novatis AG (Switzerland) • Teva Pharmaceuticals Industries Ltd. (Israel) • Request Sample Report

  5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553

More Related